Acute myeloid leukemia (AML) is a type of blood and marrow cancer. It is the most common form of acute leukemia among adults. More than half of the patients diagnosed with acute myeloid are 65 years or older; about one-third are 75 years old or older when diagnosed.
Some survivors of childhood and young adulthood cancers have been known to develop acute myeloid leukemia years after their initial treatment. This is known as "treatment-related acute leukemia."
Some patients experience a pre-leukemic phase- a condition called myelodysplasia- in which certain types of abnormal blood counts are seen. Certain types of myelodysplasia may sometimes predate the diagnosis of acute myeloid leukemia by months to years.
Why choose the Mays Cancer Center for acute myeloid leukemia?
You’ll be cared for by a multidisciplinary team led by hematologists who specialize in blood cancers. Acute myeloid leukemia patients at the Cancer Center are treated in specialized clinics and specialized hospital-based units designed for the care of patients with leukemia.
Our team, which includes pathologists who specialize in blood, marrow and lymph node cancers — called hematopathologists — is able to offer rapid comprehensive evaluations and prepare care plans after discussions at regularly conducted conferences.
Clinical-trial based treatments are available. Our hematology team partners with the National Cancer Institute and other organizations for clinical-trial-based treatment options for all patients.
We are the only National Cancer Institute (NCI) designated cancer center in Central and South Texas. Clinical trials in acute myeloid leukemia are available at the cancer center. We can offer patients experimental treatments and first-in-human clinical trials to those patients who meet the qualification guidelines.
Make an appointment
To request an appointment with our team or to make a referral to one of our physicians, please call the main number: 210-450-1000 or 800-340-2872 or email CTRCReferral@uthscsa.edu.